• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 LSD1 的可逆抑制剂虚拟筛选及结合机制的计算研究。

LSD1-Based Reversible Inhibitors Virtual Screening and Binding Mechanism Computational Study.

机构信息

School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.

School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.

出版信息

Molecules. 2023 Jul 10;28(14):5315. doi: 10.3390/molecules28145315.

DOI:10.3390/molecules28145315
PMID:37513188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10383809/
Abstract

As one of the crucial targets of epigenetics, histone lysine-specific demethylase 1 (LSD1) is significant in the occurrence and development of various tumors. Although several irreversible covalent LSD1 inhibitors have entered clinical trials, the large size and polarity of the FAD-binding pocket and undesired toxicity have focused interest on developing reversible LSD1 inhibitors. In this study, targeting the substrate-binding pocket of LSD1, structure-based and ligand-based virtual screenings were adopted to expand the potential novel structures with molecular docking and pharmacophore model strategies, respectively. Through drug-likeness evaluation, ADMET screening, molecular dynamics simulations, and binding free energy screening, we screened out one and four hit compounds from the databases of 2,029,554 compounds, respectively. Generally, these hit compounds can be divided into two categories, amide ( and ) and 1,2,4-triazolo-4,3-α-quinazoline (). Among them, exhibits the strongest binding affinity. Finally, the binding mechanisms of the hit compounds were further calculated in detail by the residue free energy decomposition. It was found that van der Waals interactions contribute most to the binding, and is also helpful in stabilizing the binding and avoiding off-target effects. We believe this work not only provides a solid theoretical foundation for the design of LSD1 substrate reversible inhibitors, but also expands the diversity of parent nucleus, offering new insights for synthetic chemists.

摘要

作为表观遗传学的关键靶点之一,组蛋白赖氨酸特异性去甲基化酶 1(LSD1)在各种肿瘤的发生和发展中具有重要意义。尽管几种不可逆的 LSD1 共价抑制剂已进入临床试验,但 FAD 结合口袋的大尺寸和极性以及不理想的毒性引起了人们对开发可逆 LSD1 抑制剂的兴趣。在这项研究中,针对 LSD1 的底物结合口袋,采用基于结构和基于配体的虚拟筛选方法,分别通过分子对接和药效团模型策略来扩展潜在的新型结构。通过药物相似性评估、ADMET 筛选、分子动力学模拟和结合自由能筛选,我们从包含 2029554 个化合物的数据库中分别筛选出一个和四个命中化合物。一般来说,这些命中化合物可以分为酰胺(和)和 1,2,4-三唑并[4,3-α]喹唑啉()两类。其中,表现出最强的结合亲和力。最后,通过残基自由能分解进一步详细计算了命中化合物的结合机制。结果发现,范德华相互作用对结合贡献最大,而也有助于稳定结合并避免脱靶效应。我们相信这项工作不仅为 LSD1 底物可逆抑制剂的设计提供了坚实的理论基础,而且还扩展了母体核的多样性,为合成化学家提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/76affff567e7/molecules-28-05315-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/b9ff8d761ea5/molecules-28-05315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/7a6c3a8da111/molecules-28-05315-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/b54cb63f1040/molecules-28-05315-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/b5ce721dcf67/molecules-28-05315-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/d433e1cc493d/molecules-28-05315-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/3425cc097727/molecules-28-05315-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/50fdbd41272f/molecules-28-05315-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/2d95d948e26c/molecules-28-05315-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/af307eb15577/molecules-28-05315-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/f5fd9872f033/molecules-28-05315-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/76affff567e7/molecules-28-05315-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/b9ff8d761ea5/molecules-28-05315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/7a6c3a8da111/molecules-28-05315-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/b54cb63f1040/molecules-28-05315-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/b5ce721dcf67/molecules-28-05315-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/d433e1cc493d/molecules-28-05315-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/3425cc097727/molecules-28-05315-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/50fdbd41272f/molecules-28-05315-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/2d95d948e26c/molecules-28-05315-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/af307eb15577/molecules-28-05315-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/f5fd9872f033/molecules-28-05315-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259d/10383809/76affff567e7/molecules-28-05315-g009.jpg

相似文献

1
LSD1-Based Reversible Inhibitors Virtual Screening and Binding Mechanism Computational Study.基于 LSD1 的可逆抑制剂虚拟筛选及结合机制的计算研究。
Molecules. 2023 Jul 10;28(14):5315. doi: 10.3390/molecules28145315.
2
Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screening.基于药效团和结构的虚拟筛选鉴定组蛋白赖氨酸特异性去甲基酶 1(LSD1)的新型抑制剂。
J Biomol Struct Dyn. 2019 Oct;37(16):4200-4214. doi: 10.1080/07391102.2018.1538903. Epub 2018 Dec 5.
3
Utilizing a structure-based virtual screening approach to discover potential LSD1 inhibitors.利用基于结构的虚拟筛选方法发现潜在的 LSD1 抑制剂。
J Cancer Res Clin Oncol. 2024 May 15;150(5):253. doi: 10.1007/s00432-024-05784-5.
4
Identification of Novel Selective Lysine-Specific Demethylase 1 (LSD1) Inhibitors Using a Pharmacophore-Based Virtual Screening Combined with Docking.基于药效团的虚拟筛选结合对接技术鉴定新型选择性赖氨酸特异性去甲基化酶1(LSD1)抑制剂
Chem Biol Drug Des. 2015 Jun;85(6):659-71. doi: 10.1111/cbdd.12461. Epub 2014 Dec 22.
5
Design, Synthesis, and In Vitro Evaluation of Novel Histone H3 Peptide-Based LSD1 Inactivators Incorporating α,α-Disubstituted Amino Acids with γ-Turn-Inducing Structures.新型组蛋白 H3 肽基 LSD1 失活剂的设计、合成及体外评价,其中包含具有 γ-转角诱导结构的α,α-二取代氨基酸。
Molecules. 2018 May 6;23(5):1099. doi: 10.3390/molecules23051099.
6
Identification of selective and reversible LSD1 inhibitors with anti-metastasis activity by high-throughput docking.通过高通量对接鉴定具有抗转移活性的选择性和可逆 LSD1 抑制剂。
Bioorg Med Chem Lett. 2019 Feb 15;29(4):544-548. doi: 10.1016/j.bmcl.2018.12.067. Epub 2019 Jan 2.
7
Mining the Dynamical Properties of Substrate and FAD Binding Pockets of LSD1: Hints for New Inhibitor Design Direction.挖掘 LSD1 底物和 FAD 结合口袋的动力学特性:新抑制剂设计方向的启示。
J Chem Inf Model. 2024 Jun 24;64(12):4773-4780. doi: 10.1021/acs.jcim.4c00398. Epub 2024 Jun 5.
8
Investigating the Binding Mode of Reversible LSD1 Inhibitors Derived from Stilbene Derivatives by 3D-QSAR, Molecular Docking, and Molecular Dynamics Simulation.通过 3D-QSAR、分子对接和分子动力学模拟研究源于二苯乙烯衍生物的可逆 LSD1 抑制剂的结合模式。
Molecules. 2019 Dec 6;24(24):4479. doi: 10.3390/molecules24244479.
9
Amino-carboxamide benzothiazoles as potential LSD1 hit inhibitors. Part I: Computational fragment-based drug design.氨基甲酰胺苯并噻唑类化合物作为潜在的赖氨酸特异性去甲基化酶1(LSD1)命中抑制剂。第一部分:基于计算的片段药物设计。
J Mol Graph Model. 2019 Dec;93:107440. doi: 10.1016/j.jmgm.2019.107440. Epub 2019 Aug 27.
10
Intermolecular insights into allosteric inhibition of histone lysine-specific demethylase 1.研究组氨酸赖氨酸特异性去甲基酶 1 的变构抑制的分子间见解。
Biochim Biophys Acta Gen Subj. 2021 Nov;1865(11):129990. doi: 10.1016/j.bbagen.2021.129990. Epub 2021 Aug 12.

引用本文的文献

1
Computer-aided drug design for the double-membrane vesicle pore complex inhibitors against SARS-CoV-2.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)双膜囊泡孔复合物抑制剂的计算机辅助药物设计
Front Microbiol. 2025 Mar 28;16:1562187. doi: 10.3389/fmicb.2025.1562187. eCollection 2025.
2
Drug repurposing to tackle parainfluenza 3 based on multi-similarities and network proximity analysis.基于多相似性和网络邻近性分析的药物重新利用以应对副流感病毒3型
Front Pharmacol. 2024 Oct 1;15:1428925. doi: 10.3389/fphar.2024.1428925. eCollection 2024.
3
Role of Computer-Aided Drug Design in Drug Development.

本文引用的文献

1
Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021.2021 年赖氨酸特异性去甲基酶 1(LSD1/KDM1A)抑制剂的年度回顾。
Eur J Med Chem. 2022 Jan 15;228:114042. doi: 10.1016/j.ejmech.2021.114042. Epub 2021 Dec 6.
2
ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties.ADMETlab 2.0:一个集成的在线平台,用于准确全面地预测 ADMET 性质。
Nucleic Acids Res. 2021 Jul 2;49(W1):W5-W14. doi: 10.1093/nar/gkab255.
3
Discovery of orally active chalcones as histone lysine specific demethylase 1 inhibitors for the treatment of leukaemia.
计算机辅助药物设计在药物研发中的作用。
Molecules. 2023 Oct 19;28(20):7160. doi: 10.3390/molecules28207160.
发现具有口服活性的查耳酮作为组蛋白赖氨酸特异性去甲基化酶 1 抑制剂用于治疗白血病。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):207-217. doi: 10.1080/14756366.2020.1852556.
4
Exploration of 5-cyano-6-phenylpyrimidin derivatives containing an 1,2,3-triazole moiety as potent FAD-based LSD1 inhibitors.含1,2,3-三唑部分的5-氰基-6-苯基嘧啶衍生物作为基于黄素腺嘌呤二核苷酸的赖氨酸特异性去甲基化酶1(LSD1)强效抑制剂的研究
Acta Pharm Sin B. 2020 Sep;10(9):1658-1668. doi: 10.1016/j.apsb.2020.02.006. Epub 2020 Feb 24.
5
Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1).CC-90011 的发现:一种有效的、选择性的赖氨酸特异性去甲基化酶 1(LSD1)可逆抑制剂。
J Med Chem. 2020 Dec 10;63(23):14522-14529. doi: 10.1021/acs.jmedchem.0c00978. Epub 2020 Oct 9.
6
Schrödinger's App.薛定谔的应用程序
Am J Law Med. 2020 May;46(2-3):203-218. doi: 10.1177/0098858820933495.
7
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer.新型可逆 LSD1 抑制剂 SP-2577 促进 SWI/SNF 复合物突变型卵巢癌中的抗肿瘤免疫。
PLoS One. 2020 Jul 10;15(7):e0235705. doi: 10.1371/journal.pone.0235705. eCollection 2020.
8
Discovery of Reversible Inhibitors of KDM1A Efficacious in Acute Myeloid Leukemia Models.在急性髓系白血病模型中有效的KDM1A可逆抑制剂的发现。
ACS Med Chem Lett. 2020 Feb 13;11(5):754-759. doi: 10.1021/acsmedchemlett.9b00604. eCollection 2020 May 14.
9
Experience-based discovery (EBD) of aryl hydrazines as new scaffolds for the development of LSD1/KDM1A inhibitors.基于经验的发现(EBD)芳基腙作为 LSD1/KDM1A 抑制剂开发的新骨架。
Eur J Med Chem. 2019 Mar 15;166:432-444. doi: 10.1016/j.ejmech.2019.01.075. Epub 2019 Feb 2.
10
Crystal Structure of LSD1 in Complex with 4-[5-(Piperidin-4-ylmethoxy)-2-(-tolyl)pyridin-3-yl]benzonitrile.LSD1 与 4-[5-(4-哌啶基甲氧基)-2-(-甲苯基)吡啶-3-基]苯腈复合物的晶体结构。
Molecules. 2018 Jun 26;23(7):1538. doi: 10.3390/molecules23071538.